Related Experiment Videos
A mesoblastic nephroma with hypercalcaemia
N F Woolfield1, G D Abbott, C U McRae
1Department of Paediatrics, Christchurch Hospital, New Zealand.
Australian Paediatric Journal
|October 1, 1988
Insights
A rare infant kidney tumor, mesoblastic nephroma, can cause dangerous hypercalcemia. Prompt treatment and tumor removal normalized calcium levels in this case, highlighting the need for vigilance.
Area of Science:
- Pediatric Oncology
- Nephrology
- Endocrinology
Background:
- Mesoblastic nephroma is a rare congenital kidney tumor.
- Hypercalcemia is a potentially life-threatening complication associated with mesoblastic nephroma.
Observation:
- A 14-week-old female infant presented with a diagnosed mesoblastic nephroma.
- The infant was found to have hypercalcemia upon presentation.
Findings:
- Hypercalcemia was successfully corrected prior to surgical tumor removal.
- Serum calcium levels normalized postoperatively and remained within the normal range.
Implications:
- Hypercalcemia is a critical complication of mesoblastic nephroma requiring prompt investigation.
- Early detection and management of hypercalcemia are crucial for patient outcomes.
Abstract:
A 14 week old female infant who presented with a mesoblastic nephroma was found to be hypercalcaemic. This was corrected prior to removal of the tumour and serum calcium concentrations remained within the normal range postoperatively. Hypercalcaemia is a life threatening complication of mesoblastic nephromas and should be investigated in all cases.